Search results
Over 70% of Low-Income Women Have No Confidence in Their Ability To Plan for Retirement — 8...
GOBankingRates via Yahoo Finance· 3 days agoWe support the Treat and Reduce Obesity Act (TROA), which is a bipartisan bill designed to ensure...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 5 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 22 hours agoExelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misses...
CVS Health (CVS) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoWe will provide updates throughout the year on these efforts. I also feel it is important to discuss our long-term outlook for Medicare Advantage. We...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 2 days agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
Q1 2024 Blueprint Medicines Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoMedicare patients were able to access paid therapy as we saw last year. Importantly, unlike last year, we expect these patients will be able to stay on therapy for the rest ...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 2 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Are Consumer Driven Health Plans the right FEHB plan for you?
Government Executive· 2 days agoConsumer Driven Health Plans or CDHPs have been around for a while, but we still get lots of...
Osteoporosis screening rates low for Asian American Medicare beneficiaries
Medical Xpress· 2 days agoRates of dual-energy X-ray absorptiometry (DXA) screening for osteoporosis are lower than expected...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...
